Intravenous albumin does not prevent moderate‐severe ovarian hyperstimulation syndrome in high‐risk IVF patients: a randomized controlled study

By Bellver José   Muñoz Elkin A.   Ballesteros Agustín   Soares Sérgio Reis   Bosch Ernesto   Simón Carlos   Pellicer Antonio   Remohí José  

Human Reproduction, Vol. 18, Iss. 11, 2003-11 ,pp. : 2283-2288

Oxford University Press

Access to resources Recommend Favorite

Does withholding gonadotrophin administration prevent severe ovarian hyperstimulation syndrome?

By Lee C   Tummon I   Martin J   Nisker J   Power S   Tekpetey F  

Human Reproduction, Vol. 13, Iss. 5, 1998-05 ,pp. : 1157-1158

Oxford University Press

Access to resources Recommend Favorite

Does triggering ovulation with gonadotrophin-releasing hormone analogue prevent severe ovarian hyperstimulation syndrome?

By Casper Robert F.  

Human Reproduction, Vol. 11, Iss. 6, 1996-06 ,pp. : 1144-1146

Oxford University Press

Access to resources Recommend Favorite

Opinion. Role of intravenous albumin in the prevention of severe ovarian hyperstimulation syndrome

By Orvieto R  

Human Reproduction, Vol. 13, Iss. 12, 1998-12 ,pp. : 3306-3309

Oxford University Press

Access to resources Recommend Favorite

Intravenous albumin for preventing severe ovarian hyperstimulation syndrome: a Cochrane review

By Aboulghar M.  

Human Reproduction, Vol. 17, Iss. 12, 2002-12 ,pp. : 3027-3032

Oxford University Press

Access to resources Recommend Favorite